Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Maintains a 'Hold' on Trex (TREX); Preannounced Weaker-than-Expected Q2 Sales
-
Canaccord Genuity Maintains a 'Hold' on Powerwave Technologies (PWAV); Guides to Low End of Full-year Guidance
-
Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Case on Inequitable Conduct Credible, but Legal Hurdle Still High
-
Canaccord Genuity Maintains a 'Hold' on Gen-Probe (GPRO); Lowering Price Target
-
UPDATE - Canaccord Genuity Downgrades Pegasystems (PEGA) to Hold; Great Run: Stock Likely High End of Valuation Range
-
Canaccord Genuity Downgrades Pegasystems (PEGA) to Hold
-
Silver Spring Networks (SSNI) Files $150M IPO
-
Apple (AAPL) iPad Should Sell More, Have Less Presence in 2012 - Canaccord
-
Canaccord Genuity Maintains a 'Buy' on Netflix (NFLX); June Traffic Slow, Q2 Ahead
-
Canaccord Genuity Reiterates a 'Sell' on Seattle Genetics (SGEN); Adcetris ODAC Panel Preview
-
Canaccord Genuity Maintains a 'Hold' on SemiLEDs (LEDS); Challenges Persist, but Assets Help Backstop Valuation
-
Canaccord Genuity Maintains a 'Hold' on Research In Motion (RIMM); Market Share Losses, Product Delays Continue
-
Canaccord Genuity Maintains a 'Hold' on Motorola Mobility (MMI); Checks Indicate Declining Android Market Share
-
Canaccord Genuity Maintains a 'Buy' on Apple (AAPL); Checks Indicate Strong Trends Ahead of iPhone 5 Launch
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); FQ3/11 Preview: Nuedexta Sales on Track, Beating 'New Normal'
-
Canaccord Genuity Maintains a 'Buy' on EnerNOC (ENOC); Making a Little Thunder Down Under;
-
Canaccord Genuity Maintains a 'Buy' on Metalico (MEA); Tighter Metal Spreads Likely to Compress Margins
-
Canaccord Genuity Reiterates a 'Buy' on OpenTable (OPEN); Reviewing the Thesis
-
Canaccord Genuity Assumes Coverage on Abraxas Petroleum (AXAS) at Buy; Bakken Development Plans in Focus After Portfolio Update
-
Canaccord Genuity Maintains a 'Hold' on Noble (NE); Downtime Lowers Q2 Estimates
-
Canaccord Genuity on Technology: Amazon (AMZN) Orders To Boost Tablet Supply Chain, Potentially Atmel (ATML) and NVIDIA (NVDA)
-
Canaccord Genuity Maintains a 'Buy' on GLG Life Tech (GLGL); European Stevia Approval Nears
-
Canaccord Genuity Assumes Coverage on Vertex (VRTX) at Hold; Shares Fairly Valued
-
Canaccord Genuity Assumes Coverage on InterMune Inc. (ITMN) at Buy
-
Canaccord Genuity on Sustainability/Recycling: Keeping a Watchful Eye on Shredding Overcapacity in the Scrap Market
-
Canaccord Genuity Assumes Coverage on Pharmasset (VRUS) at Buy; Blockbuster Potential of HCV Therapeutic Franchise
-
Canaccord Genuity Reiterates a 'Buy' on Insulet Corporation (PODD); Takeaways From the ADA
-
Canaccord Genuity Reiterates a 'Buy' on DexCom (DXCM); Takeaways from ADA; FDA Mandated Sensor Shut-off a Possibility in Future
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Nuedexta Paragraph 4: We Are confident in IP Position to 2026
-
Canaccord Genuity Reiterates a 'Buy' on Horsehead Holding (ZINC); Data Points Indicate Improving Trends
-
Canaccord Genuity Reiterates a 'Buy' on Schnitzer Steel (SCHN); Growth Strategies Show Promise
-
Canaccord Genuity Maintains a 'Hold' on Mitel (MITL); Slow and Steady Turn?
-
Canaccord Genuity Is Confirming the GE 60W Collaboration with Cree (CREE)... Again
-
Canaccord Genuity Reiterates a 'Buy' on Spreadtrum Communications (SPRD); Management Hosts Call, Declares Dividend
-
Canaccord Genuity Maintains a 'Buy' on Acuity Brands (AYI); Good Near-term Performance in a Tough Market
-
Canaccord Genuity Reiterates a 'Buy' on Autodesk (ADSK); Management Reassures Nervous Investors with Upbeat Analyst Day; 2012 Outlook Intact
-
Canaccord Genuity Reiterates a 'Buy' on Qualcomm (QCOM); Anticipate Strong QCT Market Share Gains During 2012
-
Canaccord Genuity Reiterates a 'Buy' on St. Mary's (SM); Joint Venture a Strong Positive, Guidance Update Next Catalyst
-
Canaccord Genuity Reiterates a 'Buy' on Dendreon (DNDN); Expecting Wins on CMS Decision and New Facility Approval
-
Canaccord Genuity Maintains a 'Buy' on Nalco Holding (NLC); A Deeper Dive Into the Water
-
Canaccord Genuity Reiterates a 'Buy' on Standard Microsystems (SMSC); Citing Valuation, Momentum for Autos and Audio
-
Notable Analyst Rating Changes 06/28: (TJX) (NRG) (STX) Upgraded; (JASO) (MMI) (SOL) Downgraded
-
Morning Movers 06/28: (YOKU) (ICGN) (LNKD) Higher; (AMBO) (ABH) Lower
-
Canaccord Genuity reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Nuedexta First Four Months: Slow but Solid, Steady Growth
-
Canaccord Genuity Maintains a 'Hold' on Edwards Lifesciences (EW); Surprising TAVI Consensus Document
-
Canaccord Genuity reiterates a 'Buy' on Integra LifeSciences (IART); Updating Model For Seaspine and Convert Offering
-
Canaccord Genuity reiterates a 'Buy' on Autodesk (ADSK); Likely Talking Points at this Week's Analyst Event
-
UPDATE - Canaccord Genuity Upgraded OmniVision Technologies (OVTI) to Buy on Positive Checks
-
Canaccord Genuity Upgrades OmniVision Technologies (OVTI) to Buy
-
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); Meeting With Management
